Alimta Injectable Product clinical trials

Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC

This study is testing a new cancer vaccine, PDC*lung01, for people with a type of lung cancer called Non Small Cell Lung Cancer. It’s looking at how safe it is, how the body reacts to it, and if it helps treat the cancer, sometimes alongside other proven medicines.